"Media representatives and diplomats from Germany, Sweden, the Czech Republic and France were only allowed to attend the announcement of the ruling, which sparked strong reactions internationally. The ...
Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.